Flavonoids in oral cancer prevention and therapy

European Journal of Cancer Prevention

Volumn 24, Issue 6, 2015, Pages 517-528

  Maggioni, Daniele ^a   Biffi, Luisa ^a,b   Nicolini, Gabriella ^a   Garavello, Werner ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Chemoprevention; flavonoids; oral cancer

Indexed keywords

APIGENIN; BAICALEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FLAVOPIRIDOL; GENISTEIN; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LUTEOLIN; QUERCETIN; SILIBININ;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL EVALUATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; METASTASIS INHIBITION; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; ANIMAL; MOUTH NEOPLASMS;

ANIMALS; FLAVONOIDS; HUMANS; MOUTH NEOPLASMS;

EID: 84943197951     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000109     Document Type: Review

References (108)

1. Adlercreutz H, Markkanen H, Watanabe S (1993). Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209-1210.
2. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R (2003). Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22:8271-8282.
3. Alhasan SA, Pietrasczkiwicz H, Alonso MD, Ensley J, Sarkar FH (1999). Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer 34:12-19.
4. Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H, et al. (2011). Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 47:725-731.
5. Azuine MA, Bhide SV (1994). Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 44:211-217.
6. Babich H, Krupka ME, Nissim HA, Zuckerbraun HL (2005). Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity. Toxicol In Vitro 19:231-242.
7. Balasubramanian S, Govindasamy S (1996). Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis 17:877-879.
8. Bates SE, Fojo AT, Weinstein JN, Myers TG, Alvarez M, Pauli KD, Chabner BA (1995). Molecular targets in the National Cancer Institute drug screen. J Cancer Res Clin Oncol 121:495-500.
9. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. (1988). Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282-3287.
10. Chan LP, Chou TH, Ding HY, Chen PR, Chiang FY, Kuo PL, Liang CH (2012). Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl- 2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim Biophys Acta 1820:1081-1091.
11. Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, et al. (2012). Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncol Rep 28:1799-1807.
12. Chen AY, Chen YC (2013). A review of the dietary flavonoid kaempferol on human health and cancer chemoprevention. Food Chem 138:2099-2107.
13. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC (2006). Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 85:220-225.
14. Chen SF, Nieh S, Jao SW, Liu CL, Wu CH, Chang YC, et al. (2012). Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One 7:e49275.
15. Chen SF, Nien S, Wu CH, Liu CL, Chang YC, Lin YS (2013). Reappraisal of the anticancer efficacy of quercetin in oral cancer cells. J Chin Med Assoc 76:146-152.
16. Cheng CW, Shieh PC, Lin YC, Chen YJ, Lin YH, Kuo DH, et al. (2010). Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAKPKC- delta-STAT1 signaling in human oral cancer cells. J Agric Food Chem 58:887-894.
17. Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW, Lin C (2012). Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol 263:360-367.
18. Chiang WC, Wong YK, Lin SC, Chang KW, Liu CJ (2006). Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Dis 12:27-33.
19. Corradini E, Foglia P, Giansanti P, Gubbiotti R, Samperi R, Lagana A (2011). Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Nat Prod Res 25:469-495.
20. Dasanayake AP, Silverman AJ, Warnakulasuriya S (2010). Maté drinking and oral and oro-pharyngeal cancer: a systematic review and meta-analysis. Oral Oncol 46:82-86.
21. Donald G, Hertzer K, Eibl G (2012). Baicalein - an intriguing therapeutic phytochemical in pancreatic cancer. Curr Drug Targets 13:1772-1776.
22. Drees M, Dengler WA, Roth T, Labonte H, Mayo J, Malspeis L, et al. (1997). Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. Clin Cancer Res 3:273-279.
23. Elattar TM, Virji AS (2000). The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 20 (3A):1733-1738.
24. Fan XJ (1992). In vitro effect of catechin on cell growth. Zhonghua Zhong Liu Za Zhi 14:190-192.
25. Funakoshi-Tago M, Nakamura K, Tago K, Mashino T, Kasahara T (2011). Antiinflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin. Int Immunopharmacol 11:1150-1159.
26. Gao Z, Huang K, Yang X, Xu H (1999). Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1472:643-650.
27. Garavello W, Rossi M, McLaughlin JK, Bosetti C, Negri E, Lagiou P, et al. (2007). Flavonoids and laryngeal cancer risk in Italy. Ann Oncol 18:1104-1109.
28. Garavello W, Lucenteforte E, Bosetti C, La Vecchia C (2009). The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol 58:25-34.
29. Gómez-García FJ, López-Jornet MP, Alvarez-Sánchez N, Castillo-Sánchez J, Benavente-García O, Vicente Ortega V (2013). Effect of the phenolic compounds apigenin and carnosic acid on oral carcinogenesis in hamster induced by DMBA. Oral Dis 19:279-286.
30. Gonzalez de Mejia E, Song YS, Ramirez-Mares MV, Kobayashi H (2005). Effect of yerba mate (Ilex paraguariensis) tea on topoisomerase inhibition and oral carcinoma cell proliferation. J Agric Food Chem 53:1966-1973.
31. Haghiac M, Walle T (2005). Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells. Nutr Cancer 53:220-231.
32. Hashibe M, Sturgis EM (2013). Epidemiology of oral-cavity and oropharyngeal carcinomas: controlling a tobacco epidemic while a human papillomavirus epidemic emerges. Otolaryngol Clin North Am 46:507-520.
33. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, et al. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18:541-550.
34. Hertog MG, Hollman PC, Katan MB, Kromhout D (1993). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20:21-29.
35. Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, Burman AC (2009). Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9:138-161.
36. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC (2007). Epigallocatechin-3 gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 36:588-593.
37. Hsu S, Lewis JB, Borke JL, Singh B, Dickinson DP, Caughman GB, et al. (2001). Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression. Anticancer Res 21 (6A):3743-3748.
38. Hsu S, Farrey K, Wataha J, Lewis J, Borke J, Singh B, et al. (2005). Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells. Anticancer Res 25 (1A):63-67.
39. Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, Chen Y (2012). Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res 31:48.
40. Huang CY, Chan CY, Chou IT, Lien CH, Hung HC, Lee MF (2013). Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells. J Nutr Biochem 24:1596-1603.
41. Hwang YS, Park KK, ChungWY (2013). Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma. Eur J Pharmacol 715:286-295.
42. Ishino A, Kusama K, Watanabe S, Sakagami H (1999). Inhibition of epigallocatechin gallate-induced apoptosis by CoCl2 in human oral tumor cell lines. Anticancer Res 19 (6B):5197-5201.
43. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
44. Johnson TL, Lai MB, Lai JC, Bhushan A (2010). Inhibition of cell proliferation and MAP kinase and Akt pathways in oral squamous cell carcinoma by genistein and biochanin A. Evid Based Complement Alternat Med 7:351-358.
45. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT (2005). The antitumor activities of flavonoids. In Vivo 19:895-909.
46. Kang JW, Kim JH, Song K, Kim SH, Yoon JH, Kim KS (2010). Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase- 3-dependent apoptosis in oral cavity cancer cells. Phytother Res 24 (Suppl 1):S77-S82.
47. Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, et al. (2008). Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99:647-654.
48. Kelland LR (2000). Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. Expert Opin Investig Drugs 9:2903-2911.
49. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG (1998). Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 19:419-424.
50. Kim HY, Jung SK, Byun S, Son JE, Oh MH, Lee J, et al. (2013). Raf and PI3K are the molecular targets for the anti-metastatic effect of luteolin. Phytother Res 27:1481-1488.
51. Ko SY, Chang KW, Lin SC, Hsu HC, Liu TY (2007). The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo. Cancer Lett 245:81-89.
52. Koh YW, Choi EC, Kang SU, Hwang HS, Lee MH, Pyun J, et al. (2011). Green tea (- )-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. J Nutr Biochem 22:1074-1083.
53. Lai WW, Hsu SC, Chueh FS, Chen YY, Yang JS, Lin JP, et al. (2013). Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res 33:1941-1950.
54. Lagiou P, Talamini R, Samoli E, Lagiou A, Ahrens W, Pohlabeln H, et al. (2009). Diet and upper-aerodigestive tract cancer in Europe: the ARCAGE study. Int J Cancer 124:2671-2676.
55. Lamson DW, Brignall MS (2000). Antioxidants and cancer, part 3: quercetin. Altern Med Rev 5:196-208.
56. Lee MJ, Lambert JD, Prabhu S, Meng X, Lu H, Maliakal P, et al. (2004). Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomarkers Prev 13:132-137.
57. Lin CC, Shieh DE (1996). The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24:31-36.
58. Lin CW, Chen PN, Chen MK, Yang WE, Tang CH, Yang SF, Hsieh YS (2013). Kaempferol reduces matrix metalloproteinase-2 expression by downregulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS One 8:e80883.
59. Lin SC, Wang CP, Chen YM, Lu SY, Fann MJ, Liu CJ, et al. (2002). Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes. J Pathol 198:317-325.
60. Lin YT, Yang JS, Lin HJ, Tan TW, Tang NY, Chaing JH, et al. (2007). Baicalein induces apoptosis in SCC-4 human tongue cancer cells via a Ca2+-dependent mitochondrial pathway. In Vivo 21:1053-1058.
61. Lin Y, Shi R, Wang X, Shen HM (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8:634-646.
62. Li-Weber M (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35:57-68.
63. López-Lázaro M (2009). Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9:31-59.
64. Lu Y, Joerger R, Wu C (2011). Study of the chemical composition and antimicrobial activities of ethanolic extracts from roots of Scutellaria baicalensis Georgi. J Agric Food Chem 59:10934-10942.
65. Maggioni D, Garavello W, Rigolio R, Pignataro L, Gaini R, Nicolini G (2013). Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. Int J Oncol 43:1675-1682.
66. Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R (2004). Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res 64:6349-6356.
67. Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, Hara A, Mori H (1996). Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2 hydroxychalcone, and quercetin. Cancer Res 56:4904-4909.
68. Masuda M, Suzui M, Weinstein IB (2001). Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7:4220-4229.
69. Masuda M, Suzui M, Lim JT, Weinstein IB (2003). Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 9:3486-3491.
70. Masuelli L, Marzocchella L, Quaranta A, Palumbo C, Pompa G, Izzi V, et al. (2011). Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front Biosci (Landmark Ed) 16:1060-1068.
71. Meyer MS, Joshipura K, Giovannucci E, Michaud DS (2008). A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19:895-907.
72. Miean KH, Mohamed S (2001). Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49:3106-3112.
73. Mihara M, Shintani S, Nakashiro K, Hamakawa H (2003). Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells. Oral Oncol 39:49-55.
74. Miller EG, Peacock JJ, Bourland TC, Taylor SE, Wright JM, Patil BS, Miller EG (2008). Inhibition of oral carcinogenesis by citrus flavonoids. Nutr Cancer 60:69-74.
75. Mohan KV, Gunasekaran P, Varalakshmi E, Hara Y, Nagini S (2007). In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells. Cell Biol Int 31:599-608.
76. Myoung H, Hong SP, Yun PY, Lee JH, Kim MJ (2003). Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci 94:215-220.
77. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T (2003). Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 63:824-830.
78. Nair U, Bartsch H, Nair J (2004). Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19:251-262.
79. Okazaki K, Okazaki S, Nakamura H, Kitamura Y, Hatayama K, Wakabayashi S, et al. (2002). A repeated 28-day oral dose toxicity study of genistein in rats, based on the 'Enhanced OECD Test Guideline 407' for screening endocrinedisrupting chemicals. Arch Toxicol 76:553-559.
80. Park JH, Yoon JH, Kim SA, Ahn SG, Yoon JH (2010a). (- )-Epigallocatechin- 3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncol Rep 23:585-590.
81. Park SJ, Kim MJ, Kim YK, Kim SM, Park JY, Myoung H (2010b). Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma. Cancer Lett 292:54-63.
82. Patel V, Senderowicz AM, Pinto D Jr, Igishi T, Raffeld M, Quintanilla-Martinez L, et al. (1998). Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. J Clin Invest 102:1674-1681.
83. Petersen PE (2009). Oral cancer prevention and control - the approach of the World Health Organization. Oral Oncol 45:454-460.
84. Polkowski K, Mazurek AP (2000). Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 57:135-155.
85. Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, Nagini S (2011). The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer 63:218-226.
86. Ramamurthi VP, Kumar N, Khan I, Thiyagarajan R, Kondaiah P, Nagini S (2012). Gene expression signature of DMBA-induced hamster buccal pouch carcinomas: Modulation by chlorophyllin and ellagic acid. PLoS One 7:e34628.
87. Ravishankar D, Rajora AK, Greco F, Osborn HM (2013). Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol 45:2821-2831.
88. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003). Flavonoids: promising anticancer agents Med Res Rev 23:519-534.
89. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, Lagiou P, et al. (2007). Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120:1560-1564.
90. Sedlacek H, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, et al. (1996). Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. Int J Oncol 9:1143-1168.
91. Senderowicz AM (2003). Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Cancer Chemother Pharmacol 52 (Suppl 1):S61-S73.
92. Silvan S, Manoharan S, Baskaran N, Anusuya C, Karthikeyan S, Prabhakar MM (2011). Chemopreventive potential of apigenin in 7,12-dimethylbenz(a) anthracene induced experimental oral carcinogenesis. Eur J Pharmacol 670:571-577.
93. Shukla S, Gupta S (2010). Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962-978.
94. Tan AR, Yang X, Berman A, Zhai S, Sparreboom A, Parr AL, et al. (2004). Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer. Clin Cancer Res 10:5038-5047.
95. Tsao R (2010). Chemistry and biochemistry of dietary polyphenols. Nutrients 2:1231-1246.
96. Walle T, Browning AM, Steed LL, Reed SG, Walle UK (2005). Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 135:48-52.
97. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, Walle UK (2007). Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones. Biochem Pharmacol 73:1288-1296.
98. Wang Y, Zhang L, Wang Q, Zhang D (2014). Recent advances in the nanotechnology-based drug delivery of Silybin. J Biomed Nanotechnol 10:543-558.
99. Weisburg JH, Weissman DB, Sedaghat T, Babich H (2004). In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity. Basic Clin Pharmacol Toxicol 95:191-200.
100. Woodman OL, Chan ECh (2004). Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 31:786-790.
101. World Health Organization (2002). National cancer control programmes: policies and managerial guidelines: executive summary. Geneva: WHO.
102. Yang CS, Maliakal P, Meng X (2002). Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54.
103. Yang SF, Yang WE, Kuo WH, Chang HR, Chu SC, Hsieh YS (2008a). Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol 53:287-294.
104. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS (2008b). Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res 87:401-406.
105. Ye F, Wu J, Dunn T, Yi J, Tong X, Zhang D (2004). Inhibition of cyclooxygenase-2 activity in head and neck cancer cells by genistein. Cancer Lett 211:39-46.
106. Yamamoto T, Hsu S, Lewis J,Wataha J, Dickinson D, Singh B, et al. (2003). Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther 307:230-236.
107. Yamamoto T, Digumarthi H, Aranbayeva Z, Wataha J, Lewis J, Messer R, et al. (2007). EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase. Toxicol Appl Pharmacol 224:318-325.
108. Zhang HB, Lu P, Guo QY, Zhang ZH, Meng XY (2013). Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway. Oncol Lett 5:722-728.